[Incorrect information about treatment of multiple sclerosis from the Knowledge Center]

Tidsskr Nor Laegeforen. 2007 Jun 14;127(12):1672-3; author reply 1673.
[Article in Norwegian]
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Evidence-Based Medicine
  • Health Policy
  • Humans
  • Multiple Sclerosis / drug therapy*
  • Natalizumab
  • Norway
  • Practice Guidelines as Topic

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Natalizumab